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a b s t r a c t
AVMs are vessel anomalies where a connection between arterial and venous systems is
present and the capillary bed is absent between the two. AVMs tend to present with seizures,
headaches, focal neurological deﬁcits and hemorrhage. Hemorrhage is the most common
form of presentation. AVM's have a 2–4% annual risk of hemorrhage. Certain studies report
this rate as 1%. The greatest discussion in AVM treatment is whether to use interventional
treatment or monitor with medical treatment. There are 3 modalities that can be used for
interventional treatment; microsurgical resection, endovascular embolization and stereo-
tactic radiosurgery. Combined techniques are also possible. We deﬁned the 'radical com-
bined approach' combines embolization and microsurgery. We will discuss this procedure in
this article as we believe it has several advantages.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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AVMs are vessel anomalies where a connection between
arterial and venous systems is present and the capillary bed is
absent between the two [1]. They emerge with the persistence
of arteriovenous shunts that do not contain a capillary bed
during the fetal period [2]. They consist of three main
components: feeder arteries, the nidus, and draining veins.
The nidus includes the artery, vein and cavernous channels
[3]. Parenchymal areas are present in AVMs but they are not* Corresponding author.
E-mail address: dr_hakanyilmaz@hotmail.com (H. Yilmaz).
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0028-3843/© 2017 Polish Neurological Society. Published by Elsevier Sfunctional [4]. These lesions are thought to be present at a rate
of 0.1% in the general population. According to the autopsy
studies, 12% become symptomatic during life [5]. AVMs tend to
present with seizures, headaches, focal neurological deﬁcits
and hemorrhage. Hemorrhage is the most common form of
presentation [6]. The annual risk of hemorrhage related to
AVMs is around 2–4% [7,8]. Certain studies report this rate as
1% [9,10].
The greatest discussion in AVM treatment is whether to
choose interventional treatment or monitor them with
medical treatment [11]. There are 3 modalities that can bep. z o.o. All rights reserved.
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endovascular embolization and stereotactic radiosurgery.
Multimodality treatment of AVM was deﬁned previously
[12–14]. We deﬁned the 'radical combined approach' that
combines embolization and microsurgery and describes the
principle of using the tool techniques on the same day. This
procedure has not been described before. We used radical
combined approach in 11 AVM cases between 2013 and 2015.
These cases consisted of 4 patients with Spetzler–Martin grade
2, 5 patients with grade 3, and 2 patients with grade 4 cases.
2. Operative procedure
Pre-operative preparation was performed. All patients under-
went four-vessel cerebral angiography. All imaged were
evaluated by the neurosurgery and interventional radiology
departments.Fig. 1 – PreoperativAfter the patient is administered, general anesthesia with
intratracheal intubation, central, venous and arterial vascular
access was ensured. The endovascular embolization procedure
was then started. Once the guiding catheter was inserted into a
suitable feeder artery, the lesion was accessed with a micro-
catheter. The microcatheter was advanced as far as possible
inside the nidus and liquid embolic agent (Onyx) was adminis-
tered into the lesion. The catheter was withdrawn and the
procedure ended when reﬂux was present on the catheter. This
was performed for each feeder artery individually and maximal
embolization ensured in a single session. Next, the patient was
taken to the neurosurgery operating room while still under
anesthesia and appropriate position for operation was given. A
proper craniotomy was performed, the dura was opened
carefully and the AVM nidus that had turned acutely into a
mass was circumferentially dissected from normal brain tissue.
We already knew the preoperative location in the lesion of any
superﬁcial or deep feeder arteries that had not been closed ande DSA images.
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performed after the excision of the entire nidus. The patient was
taken to intensive care to recover slowly in the postoperative
period. We present the images of our Spetzler–Martin grade 4
patient below (Figs. 1–5). In the postoperative period, there was
no mortality and no permanent neurological deﬁcit.
3. Discussion
The combined method we implemented brings a radical
solution to AVM treatment. What we want to emphasize with
the word 'radical' is a safe and complete treatment at one
session. The patient is taken to the operating room without
being awakened after maximum embolization and the AVM
resection is performed. AVM treatment should be planned
with the patient due to its morbidity and mortality risks during
as well as after the treatment. The most important point of
discussion is still whether to use interventional treatment or
just follow-up. Most recent prospective studies report the
annual hemorrhage rate of AVMs as 1%, unlike the general
knowledge [9,10]. If the physician and the patient decide for
AVM eradication despite its risks, there are three main
methods: 1) microsurgical excision, 2) endovascular emboli-
zation, 3) stereotactic radiotherapy. These three methods can
be used alone or in combination [13,14]. We should emphasize
in particular that the ARUBA study revealed medical treatment
alone to be superior to medical and interventional treatment
in terms of death or stroke rates. This was the result of
33 months of follow-up [11]. The opinion of the patient aboutFig. 2 – Cranial tomography images taken while the patient
was asleep after the embolization and before being taken
to the operation room.the treatment will of course be the most important factor in
the ﬁnal decision.
Microsurgery is the gold standard in AVM treatment. It
includes the craniotomy, careful dural opening, and circum-
ferential dissection to ensure the total removal of the AVM
nidus. The biggest advantage of surgery is the high total
obliteration rate. The limitations are anatomical accessibility,
edema due to retraction, intraoperative rupture, normal brain
tissue resection, and the risk of thrombosis in the blood vessels
supplying the normal parenchyma. The surgical mortality rate
was 0–12.2% and the permanent morbidity rate was 5.9–14.7%.
Surgical morbidity and mortality rates are consistent with the
Spetzler–Martin grading [15,16]. Vascular damage develops
after the administration of high-dose localized radiation to theFig. 3 – Post-embolization and preoperative DSA images.
Fig. 4 – Postoperative 1st day cranial tomography images.
Fig. 5 – Cranial MR and MR angiography. Images 6 months after the treatment (showing total obliteration).
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vascular structures results in vascular obliteration during a
period of approximately 2–3 years. However, the patient is
vulnerable to hemorrhage while obliteration is developing
during this period. The annual rate of hemorrhage in these
patients is the same as the natural course [17]. The morbidity
and death rates in Spetzler–Martin grade 1–3 patients was less
with microsurgery than with radiosurgery in the series of Pikus
et al. [18]. The morbidity rate after radiosurgery is around
11.1% [19]. The treatment can be performed pre-operatively
with embolic agents. This method decreases the AVM size and
also decreases the rate of clinically signiﬁcant complications
to 6.5% [20]. It can be used to shrink the AVM to the appropriate
size before radiosurgery [21]. The main strategy in pre-
microsurgical embolization is the elimination of deep arterial
feeders that are often seen at the ﬁnal stage of the surgery and
the elimination of AVM-related aneurysms away from the
resection ﬁeld. Certain interventional radiologists close all
accessible arterial pedicles. This constitutes the ﬁrst stage of
our radical combined treatment. The closure of all arterial
pedicles is controversial [22–24]. The general approach is to
close one arterial pedicle each week. It is believed this method
stabilizes local and regional hemodynamics. Besides, iatro-
genic arterial and venous thrombosis for AVM treatment
develops quickly in a wide area and can cause secondary
hemorrhage. A hemorrhage can occur with the hemorrhagic
infarct mechanism. Progressive embolization decreases this
risk [12,25,26]. This forms the basis of our approach. Once the
entire AVM nidus, feeders and drainage veins are closed with
maximum embolization, the rate of hemorrhage is very high,
especially in those with a large drainage vein. There is also a
risk of hemorrhage with partial embolization performed with
the closure of a feeder every week. For instance, this risk will be
three times as high in an AVM nidus with 3 feeders. In our
'radical combined approach', the patient is taken to the
surgery immediately without being awakened after maximum
embolization and craniotomy is performed quickly. Besides,
ﬁlling the AVM nidus with liquid embolizing agent turns the
AVM into a somewhat acute tumor and the AVM borders are
signiﬁcantly more distinct during the surgery. Perinidal edema
can occur with acute tumor formation. Craniotomy performed
immediately after embolization also creates a safety zone
regarding this matter. Risks such as hemorrhage and perinidal
edema are also present with partial embolization.
Another beneﬁt of the radical combined approach is the
patient receiving general anesthesia only once. This protects
the patient from the risks and psychological burden of
repeated general anesthesia.
Another beneﬁt of the radical combined approach is that
the AVM nidus ﬁlled with liquid embolizing agent becomes
similar to a tumor and its borders can be determined easily. In
addition, the characteristic small ﬂashes of light and smell
after the contact of embolizing agent with bipolar cautery
make determining AVM borders during circumferential dis-
section signiﬁcantly easier. The AVM nidus can be handled
just like a meningioma.
Another beneﬁt of the radical combined approach is that
the possibility of intraoperative AVM rupture is minimized.
Less bleeding and safer surgery can be possible. Besides, any
non-embolized feeders can also be closed surgically.We believe this is a safe and appropriate treatment method
for the treatment of AVMs as the procedure can be completed
in a single session and the psychological burden of the patient
is alleviated.
4. Conclusion
We created a safe interval for complications such as
hemorrhage and edema that may be seen with partial
embolization in the radical combined approach. AVM treat-
ment was completed in a single session. Thus, recurrent risks
are not encountered and the psychological burden of the
patient is decreased. Circumferential dissection is easier with
this method and the probability of rupture is lower. We believe
that the 'radical combined approach' combines embolization
and microsurgery in the best possible way. One should always
follow the general follow-up and treatment principles of
neurosurgery at all stages.
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